A novel polymeric flame retardant with phosphorous–nitrogen synergism (PVP (PR)-P-DCDA) was synthesized by polyvinyl alcohol, hydrophilic polyester resin, phosphoric acid, and dicyandiamide. 100% polyester, 100% cotton, and 50/50% cotton–polyester blended fabrics were treated with PVP (PR)-P-DCDA by impregnation method. Flammability characteristics, thermal decomposition, surface morphology, and chemical structure of treated and untreated fabrics were investigated by vertical flammability test, limiting oxygen index, differential scanning calorimetry, thermogravimetric analysis, scanning electron microscopy, and Fourier-transform infrared, respectively. Results showed that PVP (PR)-P-DCDA is an eco-friendly flame retardant system, a good char-forming flame retardant agent with superior ease of application for cotton, polyester, and cotton/polyester blends. At the industrial scale, the flame retardant agent PVP (PR)-PDCDA has been commercialized under the name Fire-off EBR.
Abstract. This paper represents the investigation on flame retardancy performance and durability of polyester /cotton (P/C) fabrics treated with a novel halogen/formaldehyde free, P-N synergetic FR finishing agent called New Fire-off. 100 % Cotton, 100 % Polyester and three different blend P/C fabrics were chosen in this study. Fabric samples were treated with New Fire-off through pad-dry-cure process. Flammability and thermal properties of the treated samples with New Fire-off were tested according to relevant ISO standard and procedures. The obtained results showed that this new finishing formulation is a good char-forming agent. However, further studies are required to achieve washing durability for the P/C blends.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.